济川药业：公司尚未实施股份回购

Company Overview - Jichuan Pharmaceutical (SH 600566) announced on December 1 that it has not implemented any share buybacks as of November 30, 2025 [1] - The current market capitalization of Jichuan Pharmaceutical is 24.9 billion yuan [1] Revenue Composition - For the year 2024, the revenue composition of Jichuan Pharmaceutical is as follows: - Heat-clearing and detoxifying products account for 33.53% - Pediatric products account for 28.11% - Digestive products account for 14.41% - Other industries account for 9.94% - Respiratory products account for 8.13% [1]